I thought TRP was undervalued at the $1.15 IPO price compared to...

I thought TRP was undervalued at the $1.15 IPO price compared to peers. When looking at phase 2 results, the results are outstanding. Assuming TRP successfully proceeds to phase 3, the price should rise. And obviously if phase 3 is successful in around 3 years time this will go bonkers. William Bost is on the team as VP of manufacturing who is a top guy in pharma manufacturing, so id assume profit margins through his work would be great. But thats all speculation for now..

Not too sure why SP opened so low and has remained low. My guess is a dump for fear factor, and slow accumulation at these prices.. I havent seen an IPO open and remain so low from day 1, seems fishy.

All in all great company based on phase 2 results, only thing that wouldve made this even better is a larger sample size of trial candidates, but hopefully that substantially increases in phase 3.


Topped up today.


Cheers,

YK